BJU international

Automated recognition of surgical phases in robot-assisted radical prostatectomy using a Hiera-based vision transformer

Liu L, Huang JF, Shi RH et al. · 2026 May 28
Study Type: Retrospective analysis with prospective validation
Key Question: Can a hierarchical vision transformer accurately recognize surgical phases in robot-assisted radical prostatectomy for real-time clinical deployment?
Key Findings:
  • The Hiera model achieved 91% overall accuracy and weighted F1-score of 0.91 on 72 RARP videos across seven surgical phases
  • 'Urethral anastomosis' and 'intrafascial dissection' showed highest performance (F1-scores 0.96 and 0.92 respectively)
  • Real-time deployment in two live procedures demonstrated stable operation without processing errors or interface interruptions
Clinical Relevance: This technology could enhance surgical education, enable real-time quality monitoring, and support standardised assessment of RARP procedures in NHS robotic surgery centres.
Limitations: Small dataset of 72 procedures limits generalisability and requires validation with larger, more diverse patient cohorts before widespread clinical adoption.
BJU international

Computed tomography-derived extracellular volume fraction is associated with high-grade recurrence in non-muscle-invasive bladder cancer treated with intravesical gemcitabine and docetaxel

Abou Chakra M, Alsamarah I, Hougen HY et al. · 2026 May 28
Study Type: Retrospective cohort study
Key Question: Does CT-derived extracellular volume fraction predict recurrence risk in high-risk non-muscle-invasive bladder cancer patients treated with intravesical gemcitabine/docetaxel?
Key Findings:
  • CT-derived ECV was the only significant predictor of high-grade recurrence-free survival (HR 1.05, 95% CI 1.03-1.08) with strong discrimination (C-statistic 0.81)
  • ECV threshold of 15% optimally stratified patients: those with ECV ≤15% had 88% vs 41% high-grade recurrence-free survival at 24 months compared to ECV >15%
  • High-grade recurrence-free survival was 76% at 12 months and 69% at 24 months overall
Clinical Relevance: This provides a practical imaging biomarker for risk stratification in patients receiving gemcitabine/docetaxel, which is increasingly used in UK practice due to BCG shortages and intolerance.
Limitations: Single-centre retrospective study with relatively short median follow-up of 17 months requires validation in larger multicentre cohorts.
BJU international

Micro- and nanoplastics in the human genitourinary system: oncological impact - a systematic review

Akpang N, Kwiatkowski J, Zapała Ł et al. · 2026 May 29
Study Type: Systematic review
Key Question: What is the prevalence and distribution of micro- and nanoplastics in human genitourinary tissues, and do they have oncological implications?
Key Findings:
  • MNPs were detected in all investigated GU tissues (kidney, prostate, testis, penis, ureter, bladder) across 14 cross-sectional studies
  • All studies comparing malignant vs adjacent non-malignant tissues consistently showed significantly higher microplastic concentrations, particle counts, and polymer diversity in tumour tissue
  • MNPs demonstrated consistent enrichment pattern in urological malignancies across different organ sites
Clinical Relevance: This suggests a potential association between microplastic exposure and urological cancer development, which could influence future risk counselling and environmental health considerations for UK urology patients.
Limitations: Substantial methodological heterogeneity across studies regarding analytical techniques and reporting metrics limits comparability and strength of conclusions.
Nature reviews. Urology

Symptoms and subtypes of patients with lower urinary tract dysfunction - insights from the Symptoms of Lower Urinary Tract Dysfunction Research Network

Yang CC, Kirkali Z, Cameron AP et al. · 2026 May 27
Study Type: Longitudinal observational cohort study and research network overview
Key Question: What are the symptom patterns and patient subtypes in lower urinary tract dysfunction, and how do they relate to traditional diagnostic categories?
Key Findings:
  • Over 1,000 men and women with LUTS were followed for 12 months using newly developed patient-reported outcome measures
  • Patients presented with broader urological symptom complexes than previously recognised, often not fitting traditional categories like overactive bladder or BPH
  • Multiple biological, psychosocial, and behavioural factors contribute to LUTS development and persistence beyond conventional urological pathophysiology
Clinical Relevance: This challenges current NHS diagnostic frameworks for LUTS by suggesting traditional categories may be inadequate for comprehensive patient assessment and treatment planning.
Limitations: This appears to be a research network overview rather than a single study report, limiting specific methodological evaluation.
Nature reviews. Urology

Single-cell and spatial RNA sequencing in prostate cancer

Ali A, Mikutenaite M, Weischenfeldt J et al. · 2026 May 28
Study Type: Review article
Key Question: How do single-cell and spatial RNA sequencing technologies advance understanding of prostate cancer biology and clinical management?
Key Findings:
  • scRNA-seq reveals complex interactions between epithelial, stromal and immune cell subtypes that drive disease heterogeneity from benign prostatic hyperplasia to metastatic cancer
  • These technologies elucidate cellular lineage plasticity and mechanisms of androgen receptor therapy resistance
  • Spatial transcriptomics combined with bioinformatic inference of copy number variants enables integrated analysis of clonal evolution and treatment resistance
Clinical Relevance: These sequencing approaches could inform patient stratification strategies, biomarker development, and novel therapeutic targets for genomic instability or tumour microenvironment modulation in NHS prostate cancer services.
Limitations: As a review article, this does not present original data or clinical validation of proposed applications.
The Journal of urology

Comparative Analysis of Ureteral Reimplantation and Dextranomer/Hyaluronic Acid Injection Between Two Centers with Systematic Review and Meta-Analysis

Kim JK, Miranda B, Rickard M et al. · 2026 May 26
Study Type: Retrospective cohort study with systematic review and meta-analysis
Key Question: How do dextranomer/hyaluronic acid injection and ureteral reimplantation compare for treating pediatric vesicoureteral reflux in terms of durability, infection rates, and perioperative burden?
Key Findings:
  • Dx/HA injection had significantly shorter operative time (21 vs 140 minutes) and length of stay (0 vs 1 day) but higher postoperative UTI rates (19.6% vs 3.8%, p<0.001) and recurrent UTI rates (11.7% vs 1.5%, p<0.001)
  • Meta-analysis showed reimplantation had superior radiographic resolution (RR for non-resolution 4.30) and lower reoperation rates (RR 6.42) compared to Dx/HA injection
  • Procedure type independently predicted UTI risk with hazard ratio 5.6 (95% CI 2.1-14.6) favouring reimplantation
Clinical Relevance: This evidence supports risk-stratified surgical planning for paediatric VUR in UK practice, helping clinicians counsel families on trade-offs between minimally invasive approaches and durability of treatment.
Limitations: Evidence certainty was limited by significant heterogeneity between studies and predominantly non-randomised data in the meta-analysis.
World journal of urology

Perioperative hyperchloremia is associated with acute kidney injury in elderly patients undergoing bipolar plasmakinetic transurethral resection of the prostate: a prospective observational study

Jia H, Zheng Q, Zhang L et al. · 2026 May 26
Study Type: Prospective observational study
Key Question: Does hyperchloremia following bipolar TURP increase the risk of acute kidney injury in elderly patients?
Key Findings:
  • Hyperchloremia (chloride ≥110 mmol/L) occurred in 11.4% of 614 patients and was strongly correlated with irrigation fluid absorption (R² = 0.68)
  • Hyperchloremic patients had significantly higher AKI rates (30.0% vs 5.1%, P<0.001) with greater severity across all KDIGO stages
  • Hyperchloremia independently predicted composite adverse outcomes (ICU admission/ventilation/RRT) with adjusted OR 6.24 (95% CI 1.29-30.00)
Clinical Relevance: This challenges the assumption that bipolar TURP eliminates metabolic complications, suggesting UK urologists should consider perioperative chloride monitoring and potentially advocate for balanced irrigation solutions.
Limitations: Observational design cannot establish causation between hyperchloremia and AKI, and generalisability may be limited to elderly patients.
World journal of urology

Sustaining a national surgical educator workforce: a mixed-methods evaluation of faculty motivation and longitudinal retention in a urology simulation boot camp

Hogg C, Wong FM, Gowda R et al. · 2026 May 27
Study Type: Mixed-methods study with quantitative motivation assessment and qualitative analysis
Key Question: What motivates UK urology simulation faculty to teach and what factors influence their long-term retention?
Key Findings:
  • Faculty were primarily driven by intrinsic motivation (mean 4.56/5) and educational purpose rather than external rewards (extrinsic motivation 3.89/5)
  • Early attrition occurs within the first two years, after which faculty typically remain engaged for 5-8+ years
  • Structural barriers (workload, rota pressures, lack of protected time) were the main drivers of attrition, not loss of motivation
Clinical Relevance: Understanding faculty motivation patterns can inform strategies to sustain the UK's surgical education workforce, particularly relevant given ongoing pressures on NHS training capacity.
Limitations: Single programme evaluation may limit generalisability to other surgical specialties or educational formats.

…and 5 more Urology articles in that week's digest.

Subscribers get the complete brief, every Monday.

Get the Urology digest in your inbox every Monday

4 weeks completely free, then £20/year. Cancel any time during your trial — no charge.

Start your free trial — Urology → No card needed to browse. We'll ask for payment details to start the trial.